$ASIX

AdvanSix Inc.

CIK:0001673985|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Sales	$ 421,284	$ 410,022	$ 825,468	$ 787,813
Costs, expenses and other:
Cost of goods sold	390,183	351,308	790,565	675,628
Selling, general and administrative expenses	22,054	25,416	44,572	48,825
Interest expense, net	2,608	2,255	5,038	3,796
Other non-operating income, net	(215)	(607)	(684)	(1,015)
Total costs, expenses and other	414,630	378,372	839,491	727,234
Income (loss) before taxes	6,654	31,650	(14,023)	60,579
Income tax expense (benefit)	3,406	279	(1,725)	5,864
Net income (loss)	$ 3,248	$ 31,371	$ (12,298)	$ 54,715
Earnings per common share
Basic (in dollars per share)	$ 0.12	$ 1.17	$ (0.46)	$ 2.04
Diluted (in dollars per share)	$ 0.12	$ 1.15	$ (0.46)	$ 2.01
Weighted average common shares outstanding
Basic (in shares)	27,046,372	26,896,037	27,013,738	26,867,252
Diluted (in shares)	27,602,088	27,223,309	27,013,738	27,248,976

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net income (loss)	$ (12,298)	$ 54,715
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	41,751	38,639
(Gain) loss on disposal of assets	134	(177)
Deferred income taxes	(1,889)	6,646
Stock-based compensation	3,878	4,287
Amortization of deferred financing fees	304	309
Changes in assets and liabilities, net of business acquisitions:
Accounts and other receivables	(33,341)	(13,994)
Inventories	42,350	(9,378)
Taxes receivable	1,095	(14,740)
Accounts payable	(22,934)	12,423
Income taxes payable	(1,027)	(663)
Accrued liabilities	(2,001)	561
Deferred income and customer advances	(12,556)	(35,680)
Other assets and liabilities	(8,760)	(10,395)
Net cash provided by (used for) operating activities	(5,294)	32,553
Cash flows from investing activities:
Expenditures for property, plant and equipment	(56,650)	(62,327)
Other investing activities	(222)	(5,891)
Net cash used for investing activities	(56,872)	(68,218)
Cash flows from financing activities:
Borrowings from line of credit	261,500	231,500
Repayments of line of credit	(201,500)	(186,500)
Principal payments of finance leases	(513)	(491)
Dividend payments	(8,627)	(8,580)
Purchase of treasury stock	(1,397)	(1,537)
Issuance of common stock	154	155
Net cash provided by financing activities	49,617	34,547
Net change in cash and cash equivalents	(12,549)	(1,118)
Cash and cash equivalents at beginning of period	19,766	19,564
Cash and cash equivalents at the end of period	7,217	18,446
Supplemental non-cash investing activities:
Capital expenditures included in accounts payable	9,301	14,762
Supplemental cash activities:
Cash paid for interest	4,452	2,297
Cash paid for income taxes, net of refund	$ 3,795	$ 15,080

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 7,217	$ 19,766
Accounts and other receivables – net	187,429	154,102
Inventories – net	194,145	236,495
Taxes receivable	20,510	21,605
Other current assets	15,560	8,639
Total current assets	424,861	440,607
Property, plant and equipment – net	964,867	963,718
Operating lease right-of-use assets	147,454	164,494
Goodwill	56,192	56,192
Intangible assets	38,570	40,095
Other assets	41,072	41,042
Total assets	1,673,016	1,706,148
Current liabilities:
Accounts payable	243,287	284,016
Accrued liabilities	43,558	45,945
Income taxes payable	73	1,100
Operating lease liabilities – short-term	42,841	44,354
Deferred income and customer advances	1,980	14,536
Total current liabilities	331,739	389,951
Deferred income taxes	152,172	154,061
Operating lease liabilities – long-term	106,100	121,201
Line of credit – long-term	275,000	215,000
Other liabilities	11,093	10,719
Total liabilities	876,104	890,932
COMMITMENTS AND CONTINGENCIES (Note 9)
STOCKHOLDERS' EQUITY
Common stock, par value $0.01; 200,000,000 shares authorized; 33,393,066 shares issued and 27,001,186 outstanding at June 30, 2026; 33,177,824 shares issued and 26,864,035 outstanding at December 31, 2025	334	332
Preferred stock, par value $0.01; 50,000,000 shares authorized and 0 shares issued and outstanding at June 30, 2026 and December 31, 2025	0	0
Treasury stock at par (6,391,880 shares at June 30, 2026; 6,313,789 shares at December 31, 2025)	(64)	(63)
Additional paid-in capital	145,991	142,932
Retained earnings	641,669	663,019
Accumulated other comprehensive income	8,982	8,996
Total stockholders' equity	796,912	815,216
Total liabilities and stockholders' equity	$ 1,673,016	$ 1,706,148